Ioannis Drygiannakis

5PUBLICATIONS
35CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Light-Controlled Modulation of 15-Lipoxygenase-1 Regulates Intestinal Inflammatory Signaling.

|Aug 29, 2024
Landscape of Interactions between Stromal and Myeloid Cells in Ileal Crohn's Disease; Indications of an Important Role for Fibroblast-Derived CCL-2.

Nikolas Dovrolis, Vassilis Valatas, Ioannis Drygiannakis

|Apr 06, 2024
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease.

Ioannis Drygiannakis, George Kolios, Eirini Filidou

|Feb 02, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.

Gabriele Dragoni, Tommaso Innocenti, Aurelién Amiot

|Aug 06, 2021
Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis.

Leonidas Kandilogiannakis, Eirini Filidou, Ioannis Drygiannakis

Pageof 1

Frequent Collaborators

3 joint publications

George Kolios

2 joint publications

Leonidas Kandilogiannakis

2 joint publications

Eirini Filidou

2 joint publications

Gesthimani Tarapatzi